Resetting Sensitivity to T Cell Redirection by Tumor Reduction and Immune Modulation

Affiliations

• ¹ Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: hanne_norseth@dfci.harvard.edu.
• ² Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
• ³ Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.